Workflow
Here's Why Siga Technologies Inc. (SIGA) Gained But Lagged the Market Today
ZACKS· 2025-04-26 06:50
In the latest trading session, Siga Technologies Inc. (SIGA) closed at $6.51, marking a +0.39% move from the previous day. The stock trailed the S&P 500, which registered a daily gain of 0.74%. Elsewhere, the Dow gained 0.05%, while the tech-heavy Nasdaq added 1.26%.The company's stock has climbed by 16.34% in the past month, exceeding the Medical sector's loss of 7.7% and the S&P 500's loss of 4.77%.The investment community will be paying close attention to the earnings performance of Siga Technologies Inc ...
Park National (PRK) Beats Q1 Earnings Estimates
ZACKS· 2025-04-26 06:45
Park National (PRK) came out with quarterly earnings of $2.57 per share, beating the Zacks Consensus Estimate of $2.20 per share. This compares to earnings of $2.15 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 16.82%. A quarter ago, it was expected that this financial services holding company would post earnings of $2.27 per share when it actually produced earnings of $2.36, delivering a surprise of 3.96%.Over the last four ...
Edison International's SCE Preferreds: High Yields From A Special Situation
Seeking Alpha· 2025-04-26 06:24
Alpha Gen Capital is a former financial advisor and his analysis is meant to provide a relatively safer income stream with CEFs and mutual funds. He has been writing about investing on Seeking Alpha for the past decade and he aims to help investors better understand how to properly construct a portfolio. Alpha Gen Capital leads the Investing Group Yield Hunting: Alt Inc Opps, where along with his team of analysts, he focuses on closed-end funds and getting yield from bonds to complement dividend portfolios. ...
Mag 7 Earnings Preview: What Can Investors Expect?
ZACKS· 2025-04-26 06:20
Key Takeaways More than 800 companies are reporting results this coming week. Among the bunch are four Mag 7 members. The Mag 7 stocks have been active participants in the market's rebound recently. We get into the heart of the Q1 earnings season this week, with more than 800 companies reporting results, including four Magnificent 7 members and 173 other S&P 500 members. We have Microsoft (MSFT) and Meta Platform (META) on deck to report results on Wednesday, April 30th, and Apple (AAPL) and Amazon (AMZN) ...
Galapagos: Targeting High Unmet Medical Need Of MCL Focus With GLPG5101
Seeking Alpha· 2025-04-26 06:16
This article is published by Terry Chrisomalis, who runs the Biotech Analysis Central pharmaceutical service on Seeking Alpha Marketplace. If you like what you read here and would like to subscribe to, I'm currently offering a two-week free trial period for subscribers to take advantage of. My service offers a deep-dive analysis of many pharmaceutical companies. The Biotech Analysis Central SA marketplace is $49 per month, but for those who sign up for the yearly plan will be able to take advantage of a 33. ...
Why Compass Pathways Stock Was a Double-Digit Winner This Week
The Motley Fool· 2025-04-26 06:13
The field of psychedelic medicine is relatively new, and because of this, certain investors consider it to be loaded with potential. That's why even minor events in companies specializing in this can be greeted with notable share price pops.Such a dynamic was in evidence with U.K.-based Compass Pathways (CMPS -4.26%) this week. On news about a step completed in a clinical trial, the company's shares rose by 13% over the period, according to data compiled by S&P Global Market Intelligence.A significant miles ...
Why Kymera Therapeutics Stock Crushed it This Week
The Motley Fool· 2025-04-26 06:03
According to data compiled by S&P Global Market Intelligence, Kymera Therapeutics (KYMR -0.86%) notched an almost 23% share price gain across this week. That made it a standout in the ever-volatile biotech sector. Investors were cheered by a pair of announcements published by the company. Patients dosed in early-stage trialKymera is a clinical-stage biotech that specializes in a mechanism known as targeted protein degradation in its medicines. On Tuesday, the company delivered encouraging news from the labo ...
Compared to Estimates, EQT (EQT) Q1 Earnings: A Look at Key Metrics
ZACKS· 2025-04-26 06:00
EQT Corporation (EQT) reported $2.15 billion in revenue for the quarter ended March 2025, representing a year-over-year increase of 25.1%. EPS of $1.18 for the same period compares to $0.82 a year ago.The reported revenue represents a surprise of +0.23% over the Zacks Consensus Estimate of $2.15 billion. With the consensus EPS estimate being $1.02, the EPS surprise was +15.69%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determi ...
Concord Medical Files Annual Report on Form 20-F for Fiscal 2024
Prnewswire· 2025-04-26 06:00
BEIJING, April 25, 2025 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention in China, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2024 (the "Annual Report") with the U.S. Securities and Exchange Commission. An electronic copy of the Annual Report can be accessed on Concord Medical's investor relations website ...
Albertsons Companies Remains A Stellar Prospect
Seeking Alpha· 2025-04-26 05:56
Amidst this market turmoil, one company that has held up surprisingly well has been grocery chain Albertsons Companies, Inc. (NYSE: ACI ). Back in January of this year, I chronicled how this stock had risen byCrude Value Insights offers you an investing service and community focused on oil and natural gas. We focus on cash flow and the companies that generate it, leading to value and growth prospects with real potential.Subscribers get to use a 50+ stock model account, in-depth cash flow analyses of E&P fir ...